Biocon informs about press release

29 Dec 2017 Evaluate

Biocon has informed about Press Release titled ‘Biocon and Mylans Biosimilar Trastuzumab Receives Approval from ANVISA, Brazil Through Their Partner Libbs’.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

290.75 1.20 (0.41%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.